| Contents | Page |
|---|---|
| Report ofthe Trustees | |
| Independent Examiner's Report |
18 |
| Statement ofFinancial Activities | 19 |
| Statement ofFinancial Position | 20 |
| Notes tothe Financial Statements | 21 |
| Detailed Statement of Financial Activities | 28 |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |
| 3.2 Commonwealth Partnerships forAntimicrobial Stewardship (CwPAMS |
|---|
| In September 2018the CPA, in partnership with the Tropical Health and Education Trust |
| (THET), received funding from the UK Department ofHealth and Social Care's Fleming Fund |
| to develop the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) |
| programme. This scheme isdelivered via THET's very successful Health Partnerships Scheme |
| (HPS). The CPA provides key technical support to the partnerships on antimicrobial |
| stewardship (AMS) and clinical pharmacy. The programme was originally due to finish in |
| May 2020 but has been granted an extension toJune 2021due tothe COVID19 pandemic. |
| The aims ofthe programme were to strengthen workforce in: |
| ~ Antimicrobial prescribing (including informed by clinical data and using decision tools) |
| ~ Antimicrobial stewardship practices (including surveillance ofuse) |
| ~ Infection prevention and control. |
| Prior to COVID19, CwPAMS involved volunteer NHS pharmacists, specialist nurses, medics |
| and health psychologists travelling to participating Commonwealth nations to work in |
| partnership with local health workers, sharing expertise and jointly tackling the growing |
| challenge of AMR. Originally, 12 partnerships were awarded grants across 4 countries: |
| Ghana, Tanzania, Uganda and Zambia, with the intention of sharing skills and knowledge, |
| and toco-create innovation in AMS. Participating teams from the NHS undertook 1-2 annual |
| placements of 1-2 weeks at hospital sites in Commonwealth countries. Between visits, |
| teams kept in touch through online mentoring arrangements. This programme ofwork has |
| the aim of supporting countries to deliver on their national AMR action plans through |
| facilitating better stewardship ofantimicrobials and infection prevention control processes. |
| By Q3, 5096 of objectives were achieved, and the original programme achieved all of its |
| planned objectives. |
| Intermediate outcomes include: |
| OUTCOME 1:LMIC healthcare institutions and workforce improved practice related to AMS |
| 1500LMIC healthcare workers trained, including 253 pharmacists in AMS —up-skilling |
| 8 role creation across projects |
| Monitoring of behavioural change has been conducted (full results pending) |
| Improved prescribing practice and collaboration between prescribers &lab —expected |
| in all by end ofprogramme |
| OUTCOME 2:AMS strategies, guidelines and tools in place and being used |
| Antimicrobial Stewardship checklist 8 behavioural tools |
| 15new or revised documents relating to AMS and AntibioticAbx prescribing practices |
| (zero before) |
| CwPAMS app (including national treatment guidelines, WHO guidelines, IPC 8 |
| surveillance) |
| Medicines &Therapeutics Committees |
| AMS champions |
| Global Point Prevalence Surveys (GPPS) in 10hospitals (previously only 1)e.g. Korle Bu |
| 2000+ bed PPS (pooled national results being used to guide national strategy, as well |
| as local intervention). |